insiderbuyingselling Posted - 1 hour ago

$IMVT new insider selling: 9827 shares. http://insiderbuyingselling.com/?t=IMVT

insiderbuyingselling Posted - 1 hour ago

$IMVT new insider selling: 34079 shares. http://insiderbuyingselling.com/?t=IMVT

RonIsWrong Posted - 10 hours ago

@a_rubaiy sold for a loss here. $IMVT watching closely, but going long at this moment isn't a great move in most places.

RonIsWrong Posted - 1 day ago

$IMVT this is not the candle I was looking for

RonIsWrong Posted - 2 days ago

$IMVT battle

s8cashhomie Posted - 2 days ago

$IMVT starter here. Will pick up more if it hits $25

RainbowTrump Posted - 2 days ago

$IMVT man wtf

BTechPimp Posted - 3 days ago

$IMVT covered my short at $29. Dumb luck. Will short again if it goes back over $35. Biohaven will drop this to $22 by May.

Jackie_O_ Posted - 4 days ago

$IMVT Picked up a little today 🙂

RNASequencing Posted - 5 days ago

$IMVT biohaven making this thing just sit here forever with overhang and now they push back data until end May

insiderbuyingselling Posted - 1 week ago

$IMVT new insider selling: 3689 shares. http://insiderbuyingselling.com/?t=IMVT

RonIsWrong Posted - 1 week ago

$IMVT lol, I must have stared at the eclipse a little too long. I do have a position. down 5% at the moment. so, $30, hold

RonIsWrong Posted - 1 week ago

$IMVT let's see if $30 can hold. just biding my time for now... (no position yet)

Capitulation_0 Posted - 2 weeks ago

$ROIV would they sell $IMVT?

Capitulation_0 Posted - 2 weeks ago

$IMVT took a stake here..

Monkey_Banana_Genius Posted - 03/28/24

$IMVT this baby bio is coiling 👀 . Legit competitive threat to ARGX. @Doozio

Doorkey Posted - 03/28/24

$IMVT 50$ .....But when?

erevnon Posted - 03/28/24

Oppenheimer initiates coverage on Immunovant $IMVT at Outperform rating and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

Quantumup Posted - 03/27/24

Oppenheimer🏁 $IMVT Outperform/$50~sees $IMVT ($5B Mcap) shifting the balance of power from $ARGX ($24B Mcap) as its anti-FcRn antibody candidates advance toward the mkt; believes batoclimab dosing flexibility/admin simplicity offer favorable differentiation vs Vyvgart. Sees IMVT-1402 =pot BiC.

RonIsWrong Posted - 03/27/24

$IMVT a big options trade came through this morning - that's the volume spike you see. Oct $40 calls. that's over $780K might get fun

DS_Trades Posted - 03/25/24

$ROIV $IMVT

Doorkey Posted - 03/25/24

$IMVT Green!

VrtcIl Posted - 03/21/24

Volume Weighted Average Price Crossover $IMVT is trending upwards and broke over Volume Weighted Average Price. Look for entries after pullbacks as long as it stays over Volume Weighted Average Price and maintains a nice and clear trend with higher highs and lows. Float: 51.6M Short Float: 12.9 %

RedBear Posted - 03/21/24

$IMVT yeah baby, another 10%+ 🚀 ripper within hours. You do homeWORK, get rewarded

Doorkey Posted - 03/21/24

$IMVT & ARGX Good buy after Roche fail in mG Missed yesterday.

OoeyGooey Posted - 03/21/24

$IMVT Saved - for now! I added a bit more, holding shares at $34.93. Not ideal but there we are. I can be patient.

RonIsWrong Posted - 03/21/24

$IMVT $30 held up. nice move today

Krazedkujo Posted - 03/21/24

$PLTR $AMD $KIRK $IMVT Watching these as well

DonCorleone77 Posted - 03/21/24

$TRML $RHHBY $IMVT $ROIV Tourmaline Bio might see weakness today after Roche MG data, says Truist Truist says Tourmaline Bio (TRML) might see weakness today after Chugai Pharmaceutical reported topline data from the Phase 3 LUMINESCE study of Enspryng, an investigational treatment for generalized myasthenia gravis, or MG. Topline Enspryng data in MG reached statistical significance, but did not meet Roche's (RHHBY) expectations for clinical benefit, the analyst noted. While Tourmaline has not initiated an MG program, the company said their decision to pursue MG will be influenced by Enspryng, the analyst additionally noted. The firm awaits details for the Enspryng MG data given that TOUR006 is a differentiated IL-6 product with improvements on ADAs compared to Roche's IL-6, according to Truist, who also thinks this news could be a positive for Buy-rated Immunovant (IMVT) and Roivant (ROIV) and the FcRn space given that Roche may not pursue MG, which would lower the competition.

TrustButVerifi Posted - 03/21/24

$IMVT Almost bought yesterday, but mostly tied up in VKTX, still a good buy! Might dab in today.